PsychiatricTimes Members: Login | Register

|     

PsychiatricTimes SearchMedica Medline Drugs

Powered by SearchMedica

 
Risk Assessment
News
Current Issues
Blogs
Special Reports
CME
Conferences
Resources
Careers
Multimedia
About Us
 

Home » Paranoid Schizophrenia

Psychiatric Times. Vol. 18 No. 10
 

Tobacco Madness

By J. Wesley Boyd, M.D., Ph.D., and Karen Lasser, M.D.
| October 1, 2000
Dr. Boyd is in private practice in psychiatry in Northampton, Mass., and is a lecturer in psychiatry at Cambridge Hospital/Harvard Medical School and in religion at Smith College. Dr. Lasser is an internist at Cambridge Health Alliance in Cambridge and Somerville, Mass., and is a clinical fellow in medicine at Harvard Medical School.

Those who suffer from mental illness smoke cigarettes at astoundingly high rates compared to those without some form of mental illness. We have published data showing that between 50% and 80% of those suffering from a major mental illness (such as major depression, bipolar disorder, generalized anxiety disorder and schizophrenia, among others) smoke, whereas less than 40% of those who have never had mental illness smoke (Lasser et al., 2000). In all, people with mental illness consume 44% of all cigarettes in the United States, an exceedingly high figure that might surprise even the most sanguine mental health care professional.

This statistic bears within it numerous individual stories of pain and suffering. Consider the case of one of our patients, whose woeful story no doubt mirrors that of many others we treat who suffer with chronic mental illness:

"Mario" started hearing voices over a decade ago after experimenting with LSD, developing a prolonged psychosis that required several extended stays in psychiatric hospitals with a diagnosis of chronic paranoid schizophrenia. At 35 years old, Mario is perpetually disheveled, with a starry look in his eyes. Mario receives $650 per month from Social Security for disability and, except for his occasional brief forays into the working world (which usually end when voices tell him to quit or when he decides that his bosses are conspiring against him), has no other income. He spends $350 on rent for a subsidized apartment in western Massachusetts and about $50 per month on food beyond what his food stamps will pay.

Like so many others with chronic mental illness, at two packs per day and about $4 per pack, the rest of Mario's money -- roughly $240 per month, nearly 37% of his total monthly income -- goes to cigarettes. Since virtually all of Mario's income comes from the government, in a more cynical moment we might think that he is little more than a bagman whose job is to deliver government money to Big Tobacco.

What will become of Mario in 30 years, almost $100,000 in cigarettes later? Perhaps, like one 65-year-old patient with schizophrenia we met, as a result of smoking-related damage to his respiratory tract, Mario will become an "aspiration risk," unable to prevent food from passing down his trachea into his lungs. And maybe, like this patient, Mario will develop repeated pneumonias, will require frequent ventilation support in the intensive care unit and eventually will need a feeding tube placed directly into his stomach to prevent further pneumonias, costing our health care system thousands of dollars.

Or, perhaps like another 65-year-old patient with schizophrenia we have encountered, Mario will develop a massive lung cancer that, because of his psychosis, he will refuse to have treated.

Tobacco hits the mentally ill especially hard. Roughly one-third of all smokers will die early because of their habit (American Lung Association, 2001). Living with lung cancer or emphysema is hard enough, but imagine trying to make decisions about treatment options or end-of-life issues in the midst of a dark depression or active psychosis. Those with mental illness are often the least capable of coping with the devastating medical illnesses caused by smoking.

Various groups use the association between mental illness and smoking to their advantage. Psychiatric units that allow smoking are generally much more popular among patients than smoke-free units and thus generate more revenue. Many of these psychiatric units further use smoking to their advantage by offering cigarette privileges as rewards for good behavior. At one local unit, patients who break minor rules (such as yelling or refusing to participate in groups) are not allowed to go on the next scheduled smoke break. (At that unit, there were six such breaks throughout the day.) Those patients who are assaultive or require restraints are not allowed to smoke for 24 hours.

The tobacco industry also uses the association between mental illness and cigarette smoking to its advantage. R.J. Reynolds Tobacco Co. noted the perception among smokers that tobacco "helps perk you up" and "helps you think out problems," as well as providing "anxiety relief," and helping people "gain self-control," "calm down" and "cope with stress" (Nordine, 1981, as cited in Lasser et al., 2000). (Recent studies have shown that the opposite is true and that smoking often precedes the onset of mental illness.)

Could the tobacco industry be unaware that advertising that highlights the youthful, healthy effects of smoking might be particularly appealing to those with mental illness? After all, the Marlboro Man is the epitome of calm self-assuredness. He does not appear to be anxious, depressed or hallucinating -- though we might wonder if he gets a bit sad riding all alone. Have all of his cowboy buddies passed on to the great prairie in the sky because of their tobacco habits?

Unfortunately, tobacco does not deliver any mental health benefit. In fact, it directly contributes to depression and anxiety. In addition, its physical effects -- emphysema, cancer and heart disease -- can certainly make a person feel blue. If the tobacco companies have not hesitated to peddle their goods to children and the Third World, why should we presume they do not also target those with mental illness -- the group that comprises 44% of their market?

What should we do with this information? First, we need to pressure tobacco companies not to mislead their customers by falsely promoting their products as avatars of health. Those with mental illness probably have a more difficult time than most sorting out the specious claims and implications of tobacco advertising. Second, physicians need to target their patients with mental illness for smoking-cessation efforts. People with mental illness are able to quit smoking, despite some attitudes to the contrary. Third, parents should be alert to the smoking habits of their children -- a child who begins smoking may be at increased risk for mental health problems (including substance abuse) and warrants close observation. Fourth, we need to advocate raising taxes on tobacco. Studies have shown that increased cigarette taxes cut cigarette consumption by teenagers. Perhaps the same would be true for the chronically mentally ill, many of whom, like Mario, have very limited incomes. Fifth, we should pressure our legislators to expand Medicaid coverage (which is the only insurance many with mental illness have) to include smoking-cessation counseling and medications. Finally, we ought to work to ensure that all of the money that states receive in settlements from Big Tobacco be earmarked for tobacco control. Some of this money should be devoted specifically to smoking-cessation and tobacco education efforts aimed at the mentally ill.

We must do all we can to protect everyone, especially our patients who are among our society's most vulnerable, from the devastating effects of tobacco.

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.





References
1. American Lung Association (2001), Quitting smoking: Why should cigarette smokers think about quitting? Available at: www.lungusa.org/tobacco/quitting_smoke.html. Accessed Aug. 30.
2. Lasser K, Boyd JW, Woolhandler S et al. (2000), Smoking and mental illness. A population-based prevalence study. JAMA 284(20):2606-2610.


 
RELATED TOPICS

Disorganized schizophrenia
Paranoid schizophrenia
Childhood schizophrenia
Catatonic schizophrenia
Schizophrenia and disorders with psychotic features
Schizotypal personality disorder


 
TOPIC INDEX

Addiction Medicine
Alzheimer Disease
Anxiety Disorders
ADHD
Bipolar Disorder
Child & Adolescent Psychiatry
Dementia
Depression
DSM-5
Geriatric Psychiatry

 

Health Care Reform
Major Depressive
Disorder
OCD
Personality Disorders
Schizoaffective Disorder
Schizophrenia
Sleep Disorders
Somatoform Disorders
All Topics

 

 
FROM PHYSICIANS PRACTICE
Five Steps to Improving Patient Access
Judy Capko,  May 21, 2013
Patient access is getting increased attention through reform initiatives. Here are five steps you can take to make sure patients get appropriate access to care in your office.
Growing HIPAA Threat – Ignore Windows XP at Your Own Peril
Marion K. Jenkins,  May 21, 2013
Chances are good that you have some major ticking software time bombs lurking in your medical practice's computer environment, namely Windows XP and Server 2003.
Finding Physician Work-Life Balance in the Small Moments
Jennifer Frank, MD,  May 21, 2013
At my practice and at home, things are always busy. There's laundry or homework, or a patient with needs.
Three Areas to Reduce Costs at Your Medical Practice
Greg Mertz,  May 19, 2013
By taking a hard look at reducing costs for staffing, overhead, and technology at your medical practice, you may see increased physician compensation.
Dos and Don’ts for Starting a Physician Blog
Michael Woo-Ming, MD,  May 18, 2013
Starting a physician blog can provide your medical practice with marketing benefits, but it's important to do it right.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Developmental Psychopathology Comes of Age
  • The Moral Struggles of Practicing Psychiatrists
  • Grief and Depression: The Sages Knew the Difference
  • Update on Mental Health Benefits and Substance Use Disorder Services Under the Affordable Care Act
  • Synthetic Cathinones: Signs, Symptoms, and Treatment
  • Grief and Depression: The Sages Knew the Difference
  • Successful Aging: Strategies to Help Maintain and Nurture a Healthy Brain
  • Synthetic Cathinones: Signs, Symptoms, and Treatment
  • Developmental Psychopathology Comes of Age
  • Psychiatry and the Myth of “Medicalization”
  • Experts Discuss Changes, Updates in DSM-5
  • The Paradox of Choice: When More Medications Mean Less Treatment
  • Will Your Clinical Records Support You in Court?
  • Refinements in ECT Techniques
  • Successful Aging: Strategies to Help Maintain and Nurture a Healthy Brain
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • Grief and Depression: The Sages Knew the Difference
  • Psychiatry and the Myth of “Medicalization”
  • Is it Time for a Treatment Manual to Complement DSM-5?
  • NIMH vs DSM 5: No One Wins, Patients Lose
  • DSM-5 Won’t Solve the Overdiagnosis Problem—But Clinicians Can
  • The Paradox of Choice: When More Medications Mean Less Treatment
  • Experts Discuss Changes, Updates in DSM-5
  • New Insight Into the Neurobiology of Depression
  • Tie One On for Patients
  • NIMH vs DSM 5: No One Wins, Patients Lose
Click here to subscribe to our newsletter
 
CAREER CENTER

  •   Featured Jobs  
  •    Resources   
  • Psychiatry and Nurse Practitioner Opportunities
  • Associate Medical Director - Psychiatrist Delray Beach, Florida
  • Retiring Child Psychiatrist Seeks Replacement August 2010 or Before
  • Chairperson, Dept of Psychiatry Needed
  • FT Staff Psychiatrist - Excellent Benefits
  • BC Adult and Child Psychiatrits - PT and FT Positions Available
  • Managing Risks When Practicing in Three-Party Care Settings
  • 12 Tips for Making Your Practice Greener
  • Keys to Avoiding Malpractice: Standard of Care in Psychiatric Practice
  • Take This Job and Shove It
  • Merging Administrative and Academic Careers in Psychiatry
 
CME
Advances in Psychiatric Medicine: Schizophrenia Versus Schizoaffective Disorder: Clinical Implications for Therapeutic Decisions
Atypical Antipsychotics for Children and Adolescents With Schizophrenia-Spectrum Disorders
More Schizophrenia CME


 
SEARCH MEDICA

Find peer-reviewed literature and websites for practicing medical professionals

CME on Paranoid Schizophrenia
Evidence on Paranoid Schizophrenia
Guidelines on Paranoid Schizophrenia
Patient Education on Paranoid Schizophrenia
Clinical Trials on Paranoid Schizophrenia
Practical Articles on Paranoid Schizophrenia
Research and Reviews on Paranoid Schizophrenia
All "Paranoid Schizophrenia" results


CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy